Quigly...he's just a turd that shows up when the stock drops and hides when it's up. Just flush him for good.
There is no way you can be this negative and ignorant on a stock. someone must be paying you to write this #$%$ that everyone knows is BS. Why don't you save your efforts to something more productive if you can...
Sentiment: Strong Buy
Just out of curiosity, I looked. If incy does the opposite of IBB, that would be the first time in sept it didn't move in the same direction.
9/15: both down
9/12: both down
9/11: both down
9/10: both up
9/9: both down
9/8: both up
9/5: both down
9/4: both down
9/3: both down
9/2: both down
Just for your records bud...
You're always low on sales. We'll see some benefit from having detailers allowed to talk about survival, and a little benefit from RECAP. So 99MM sales. Another mil or 2 on royalty, too (survival benefit). But expenses could maybe be higher than you guess, too. I'm presuming that the checkpoint collaboration payments go onto the contract line, which makes that highly uncertain. Constraint on earnings is that this isn't a quarter in which management is highly motivated to show the first ongoing-operating profit (the first quarter of the PV push is pretty much guaranteed to generate a loss; why go black only to go red again?). They have not scrimped to make the numbers look better, so there should still be a loss.
Ha ha ha, wait till the end of the day. If it's still true, I'll admit that my hypothesis/onservation is wrong 1 day out of 5
contract revenue 28m
sg and a 130m
NET LOSS 7m 170m shares is -.04 per share
estimates are for -.02
revenue of 142
looking like another kick to the %^&^% for incyte
ok agree to disagree, incyte has had only positive news in the last week, gild would be bad news, whether they are the same or not based on beta, gild has had up greatly and incyte has beyond rolled over.....and if you go back a few posts ago, i talked aabout a swoon in bio tech, and SPECIFICALLY mentioned incyte getting slammed and PCYC and SGEN, flat and green
All I'm saying is that you'd do better comparing similar companies in similar circumstances. i.e. Apples to apples if you will. Sgen comes to mind, similar size, similar prospects, similar performance.
Pretty much any pharma has been left in the dust if compared to gild, even ones like celgene and Amgen. I get the gild connection but comparisons just don't mean much when you're talking about a company that just rolled out a mega BB vs a small-mid size biotech like incy
good for gild, then. incyte was 54.20 last day of aug today it was 46.1 nearly 20% , ibb was 276 last day of august 266 today,,,,,,,,seems like your ibb talk is crap a real different type of correction if you ask me, so, if ibb went to 200 incyte would be in the teens then eh??? AND the fact that incyte was upgraded and they have a 10 page article why gild would buy them in seeking alpha
And sovaldi is special circumstance in pharma. It's pretty much the only drug to come out of the gate as a mega blockbuster right away, which explains their meteoric rise, even for a company of that size with low beta
Gild isn't down more because their intentions to sell sovaldi through other companies was announced last week. They dropped 12% intraday, but recovered. It was finalized today. If this was the first we heard about their plan it would have certainly dropped more
did not say that, i said ages ago, that incyte quite working as you say, ibb goes up incy goes up and vice versa, i understand exactly how it works: gild gives away, 91 counties worth of dollars in their own pockets, there is no other drug on the market for hep c.......are they feeling outside pressure on the price of the drug? no other drug company has ever given away generics to the rest of the world in what 7-9 months post approval of solvaldi! To me as one who has invested in the mkts with 40 years of experience, and it is down only 2.5% at the max is incredible, why is it not down more? this is news to me as an investor means time to leave a stock like gild, so why is a stock like incyte with no news down more......ibb goes up as you say, incy goes down, ibb as you say incy goes down double more....oh you make great sense
well, ibb is down, but incy makes up 4% of fbt, that went from the mid 70s to nearly 94, while incy has done nothing, explain that, if you think you are so smart, azz wipe
IBB is down 2%, that's huge. If you understood how Beta worked, you'd realize that stocks with high Beta like Incy fluctuate more than stocks with low Beta, like GILD.
In fact, I'm surprised incy isn't down 5% but there's still time for that.
Hey how bout that PDUFA date? You idiot